Royal Bank Of Canada Raises Addus HomeCare (NASDAQ:ADUS) Price Target to $139.00

Addus HomeCare (NASDAQ:ADUSGet Free Report) had its price target hoisted by equities researchers at Royal Bank Of Canada from $134.00 to $139.00 in a report released on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 22.74% from the company’s previous close.

Several other research firms have also recently issued reports on ADUS. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, October 8th. TD Cowen increased their target price on Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research report on Wednesday. JMP Securities restated a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a research note on Wednesday, July 16th. Stephens reiterated an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a report on Wednesday, September 3rd. Finally, Cowen reissued a “buy” rating on shares of Addus HomeCare in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $139.25.

View Our Latest Research Report on Addus HomeCare

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $0.94 on Friday, hitting $113.25. The company’s stock had a trading volume of 80,114 shares, compared to its average volume of 182,139. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a 50 day moving average of $115.35 and a 200-day moving average of $112.47. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 1.87 and a beta of 0.88.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, November 3rd. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.53 by $0.03. The business had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The business’s revenue for the quarter was up 25.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.30 earnings per share. As a group, research analysts predict that Addus HomeCare will post 4.59 EPS for the current year.

Insider Transactions at Addus HomeCare

In related news, Director Veronica Hill-Milbourne sold 1,571 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director directly owned 5,067 shares of the company’s stock, valued at approximately $582,350.31. This represents a 23.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of the business’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the sale, the executive vice president owned 56,980 shares of the company’s stock, valued at approximately $6,656,403.60. The trade was a 11.96% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 34,310 shares of company stock worth $3,958,375. 4.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors have recently made changes to their positions in ADUS. Nordea Investment Management AB increased its position in Addus HomeCare by 0.3% in the second quarter. Nordea Investment Management AB now owns 36,159 shares of the company’s stock worth $4,131,000 after buying an additional 111 shares during the period. Maryland State Retirement & Pension System grew its position in shares of Addus HomeCare by 1.9% during the second quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company’s stock worth $615,000 after acquiring an additional 101 shares during the last quarter. Strs Ohio acquired a new stake in shares of Addus HomeCare in the 1st quarter worth about $653,000. Harbor Capital Advisors Inc. lifted its position in Addus HomeCare by 4.5% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 67,219 shares of the company’s stock valued at $7,743,000 after purchasing an additional 2,906 shares during the last quarter. Finally, Premier Fund Managers Ltd acquired a new position in Addus HomeCare during the 1st quarter valued at about $726,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.